InsiderTrades

Form 4 for LNTH Lantheus Holdings, Inc.

Accepted 2024-06-20 00:00:00 ET · period of report 2024-06-17 · accession 0000950170-24-075627 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-06-20 2024-06-17 LNTH Humphrey Jeffrey Chief Medical Off A - Grant $82.63 +9,076 9,076 New +$749.9K
D 2024-06-20 2024-06-17 LNTH Humphrey Jeffrey Chief Medical Off A - Grant $0.00 +16.2K 16.2K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-06-17 A A 9,076 $82.63 9,076 D — —
2 Derivative Stock Option (right to buy) 2024-06-17 A A 16,188 $0.00 16,188 D $82.63 · — to 2034-06-17 16,188 Common Stock (F2) The option vests in three equal annual installments beginning on June 17, 2025.